{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:53:14Z","timestamp":1773291194933,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.plefa.2003.08.009","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"385-391","source":"Crossref","is-referenced-by-count":23,"title":["Environmental factors and membrane polyunsaturated fatty acids in schizophrenia"],"prefix":"10.1016","volume":"69","author":[{"given":"Ravinder D","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey K","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2003.08.009_BIB1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0006-3223(00)00986-0","article-title":"Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group","volume":"49","author":"Assies","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-1781(96)02899-5","article-title":"Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients","volume":"63","author":"Mahadik","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0952-3278(96)90148-9","article-title":"Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation","volume":"55","author":"Peet","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2003.08.009_BIB6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-9964(94)90045-0","article-title":"Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(89)90146-7","article-title":"A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia","volume":"27","author":"Vaddadi","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB9","doi-asserted-by":"crossref","unstructured":"R. Reddy, M.S. Keshavan, J.K. Yao, Reduced red blood cell membrane essential polyunsaturated fatty acids in first-episode schizophrenia at neuroleptic-na\u0131\u0308ve baseline, Schizophr. Bull., in press.","DOI":"10.1093\/oxfordjournals.schbul.a007140"},{"key":"10.1016\/j.plefa.2003.08.009_BIB10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB11","doi-asserted-by":"crossref","unstructured":"D.R. Evans, V.V. Parikh, M.M. Khan, C. Coussons, P.F. Buckley, S.P. Mahadik, Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment, Prostaglandins Leukot. Essent. Fatty Acids, this issue, doi:10.1016\/j.plefa.2003.08.010.","DOI":"10.1016\/j.plefa.2003.08.010"},{"key":"10.1016\/j.plefa.2003.08.009_BIB12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(94)90048-5","article-title":"Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-na\u0131\u0308ve patients at the onset of psychosis","volume":"13","author":"Mahadik","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0952-3278(96)90138-6","article-title":"Schizophrenia as a membrane lipid disorder which is expressed throughout the body","volume":"55","author":"Horrobin","year":"1996","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2003.08.009_BIB14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-3223(02)01549-4","article-title":"Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder","volume":"53","author":"Hibbeln","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB15","doi-asserted-by":"crossref","unstructured":"Anonymous, Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia, Scottish Schizophrenia Research Group, Br. J. Psychiatry 176 (2000) 290\u2013293.","DOI":"10.1192\/bjp.176.3.290"},{"key":"10.1016\/j.plefa.2003.08.009_BIB16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric outpatients","volume":"143","author":"Hughes","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0920-9964(01)00327-9","article-title":"Schizophrenia and tobacco smoking in a Spanish psychiatric hospital","volume":"58","author":"Llerena","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(92)90024-Y","article-title":"Smoking and schizophrenia","volume":"8","author":"Lohr","year":"1992","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1037\/0021-843X.111.4.687","article-title":"Nicotine and familial vulnerability to schizophrenia","volume":"111","author":"Lyons","year":"2002","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1096-8628(20000403)96:2<173::AID-AJMG10>3.0.CO;2-U","article-title":"Schizophrenia and smoking","volume":"96","author":"Stassen","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.plefa.2003.08.009_BIB22","series-title":"Free Radicals in Brain Physiology and Disorders","year":"1996"},{"key":"10.1016\/j.plefa.2003.08.009_BIB23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.1991.01810360061009","article-title":"Oxygen radicals and neuropsychiatric illness. Some speculations","volume":"48","author":"Lohr","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1289\/ehp.8564111","article-title":"Free-radical chemistry of cigarette smoke and its toxicological implications","volume":"64","author":"Church","year":"1985","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.plefa.2003.08.009_BIB25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.110.1.159","article-title":"Exhaled ethane and antioxidant vitamin supplements in active smokers","volume":"110","author":"Do","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.plefa.2003.08.009_BIB26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/146642409311300209","article-title":"Cigarette smoking and health","volume":"113","author":"Halliwell","year":"1993","journal-title":"J. R. Soc. Health"},{"key":"10.1016\/j.plefa.2003.08.009_BIB27","series-title":"Phospholipid Spectrum Disorder in Psychiatry","first-page":"75","article-title":"Membrane protective strategies in schizophrenia","author":"Reddy","year":"1999"},{"key":"10.1016\/j.plefa.2003.08.009_BIB28","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/BF02637055","article-title":"Determinants of antioxidant status in humans","volume":"31","author":"Papas","year":"1996","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2003.08.009_BIB29","doi-asserted-by":"crossref","first-page":"1490S","DOI":"10.1093\/ajcn\/62.6.1490S","article-title":"Dietary antioxidants and cigarette smoke-induced biomolecular damage","volume":"61","author":"Eiserich","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2003.08.009_BIB30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0031-9384(96)00328-9","article-title":"Quitting smoking raises whole blood glutathione","volume":"60","author":"Lane","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.plefa.2003.08.009_BIB31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.171.6.502","article-title":"Excess mortality of schizophrenia. A meta-analysis","volume":"171","author":"Brown","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.CIR.96.4.1097","article-title":"Association between cigarette smoking and lipid peroxidation in a controlled feeding study","volume":"96","author":"Miller III","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.plefa.2003.08.009_BIB33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage","volume":"332","author":"Morrow","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.plefa.2003.08.009_BIB34","first-page":"173","article-title":"Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress","volume":"14","author":"Hulea","year":"1995","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/aje\/kwf029","article-title":"Factors associated with oxidative stress in human populations","volume":"156","author":"Block","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.48.4.385","article-title":"Free radical activity in young adult cigarette smokers","volume":"48","author":"Leonard","year":"1995","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/cs0910107","article-title":"Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men","volume":"91","author":"Brown","year":"1996","journal-title":"Clin. Sci. (London)"},{"key":"10.1016\/j.plefa.2003.08.009_BIB38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.110.1.159","article-title":"Exhaled ethane and antioxidant vitamin supplements in active smokers","volume":"110","author":"Do","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.plefa.2003.08.009_BIB39","unstructured":"K.T. Zondervan, M.C. Ocke, H.A. Smit, J.C. Seidell, Do dietary and supplementary intakes of antioxidants differ with smoking status? (cited in [65])."},{"key":"10.1016\/j.plefa.2003.08.009_BIB40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1079\/BJN19950064","article-title":"Relationship between smoking and antioxidant nutrient status","volume":"73","author":"Faruque","year":"1995","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.plefa.2003.08.009_BIB41","first-page":"44","article-title":"The effect of peripheral vascular disease on the serum levels of natural anti-oxidants","volume":"21","author":"Krijgsman","year":"2002","journal-title":"Int. Angiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0021-9150(97)00232-3","article-title":"Association of smoking and low serum bilirubin antioxidant concentrations","volume":"136","author":"Schwertner","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plefa.2003.08.009_BIB43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/77.1.160","article-title":"Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes","volume":"77","author":"Dietrich","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2003.08.009_BIB44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/sj.ejcn.1601176","article-title":"Fatty acid status of women of reproductive age","volume":"55","author":"Berry","year":"2001","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2003.08.009_BIB45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/oxfordjournals.aje.a116131","article-title":"Polyunsaturated fatty acids in adipose tissue in European men aged 38 years in relation to serum lipids, smoking habits, and fat distribution","volume":"134","author":"Seidell","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB46","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(05)61476-6","article-title":"Long-chain polyunsaturated fatty acids, infant formula, and breastfeeding","volume":"352","author":"Agostoni","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.plefa.2003.08.009_BIB47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/plef.2002.0403","article-title":"Regulation of PUFA metabolism","volume":"67","author":"Rise","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.plefa.2003.08.009_BIB48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ije\/22.5.824","article-title":"Comparison of a food frequency questionnaire with a 10-day weighed record in cigarette smokers","volume":"22","author":"Thompson","year":"1993","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a008933","article-title":"Relation of smoking and alcohol consumption to serum fatty acids","volume":"144","author":"Simon","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB50","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1007\/BF02562319","article-title":"The effects of cigarette smoking on the metabolism of essential fatty acids","volume":"34","author":"Pawlosky","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.plefa.2003.08.009_BIB51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(02)00208-6","article-title":"Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia","volume":"60","author":"Yang","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1176\/appi.ajp.160.1.188","article-title":"Omega-3 fatty acid for schizophrenia","volume":"160","author":"Horrobin","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1568015033357797","article-title":"Membrane pathology in schizophrenia","volume":"3","author":"Yao","year":"2003","journal-title":"Curr. Med. Chem. Central Nervous Syst. Agent"},{"key":"10.1016\/j.plefa.2003.08.009_BIB54","series-title":"Handbook of Clinical Neurology, Vol. 22: Neurodystrophies and Neurolipidoses","first-page":"33","article-title":"Biochemistry of lipids","author":"Morell","year":"1996"},{"key":"10.1016\/j.plefa.2003.08.009_BIB55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(00)00017-5","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"40","author":"Lauritzen","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB57","series-title":"Phospholipid Spectrum Disorder in Psychiatry","first-page":"167","article-title":"Cultural and socioeconomic differences in dietary intake of essential fatty acids and antioxidants\u2014effects on the outcome","author":"Mahadik","year":"1999"},{"key":"10.1016\/j.plefa.2003.08.009_BIB58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s001270050068","article-title":"The Dutch famine and schizophrenia spectrum disorders","volume":"33","author":"Hoek","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.plefa.2003.08.009_BIB59","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/appi.ajp.157.7.1170","article-title":"Prenatal exposure to famine and brain morphology in schizophrenia","volume":"157","author":"Hulshoff Pol","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000067960","article-title":"Can breast-feeding protect against schizophrenia? Case\u2013control Study","volume":"83","author":"Amore","year":"2003","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.plefa.2003.08.009_BIB61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ajcn\/45.2.443","article-title":"Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids","volume":"451","author":"Dougherty","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2003.08.009_BIB62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/01635589109514156","article-title":"Long-term storage of red blood cells and correlations between red cell and dietary fatty acids","volume":"16","author":"Stanford","year":"1991","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.plefa.2003.08.009_BIB63","unstructured":"M. Strassnig, J.S. Brar, R. Ganguli, Nutritional assessment of patients with schizophrenia. Schizophr. Bull., in press."},{"key":"10.1016\/j.plefa.2003.08.009_BIB64","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ps\/79.7.961","article-title":"Human requirement for N-3 polyunsaturated fatty acids","volume":"79","author":"Simopoulos","year":"2000","journal-title":"Poult. Sci."},{"key":"10.1016\/j.plefa.2003.08.009_BIB65","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0022-2275(20)32206-9","article-title":"Sources of eicosanoid precursor fatty acid pools in tissues","volume":"42","author":"Zhou","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2003.08.009_BIB66","series-title":"Dietary Lipids and Postnatal Development","first-page":"127","article-title":"Essential fatty acid deficiency in humans","author":"Holman","year":"1973"},{"key":"10.1016\/j.plefa.2003.08.009_BIB67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0006-3223(89)90216-3","article-title":"Essential fatty acids in plasma phospholipids in schizophrenics","volume":"25","author":"Horrobin","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-3223(91)90291-S","article-title":"Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan","volume":"30","author":"Kaiya","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.plefa.2003.08.009_BIB69","series-title":"Nicotine in Psychiatry: Psychopathology and Emerging Therapeutics","first-page":"111","article-title":"Nicotine and major mental disorders","author":"Kirch","year":"2000"},{"key":"10.1016\/j.plefa.2003.08.009_BIB70","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/schbul\/22.3.413","article-title":"Medical comorbidity in schizophrenia","volume":"22","author":"Jeste","year":"1996","journal-title":"Schizophr. Bull."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327803001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327803001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T23:39:04Z","timestamp":1623541144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327803001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0952327803001613"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2003.08.009","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}